SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-22-000112
Filing Date
2022-11-14
Accepted
2022-11-14 08:33:33
Documents
46
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20220930.htm   iXBRL 10-Q 1392791
2 EX-31.1 lumo-2022930x10qxex31111.htm EX-31.1 10131
3 EX-31.2 lumo-2022930x10qxex31211.htm EX-31.2 10182
4 EX-32.1 lumo-2022930x10qxex32111.htm EX-32.1 7171
10 nlnk-20220930_g1.jpg GRAPHIC 12762
11 nlnk-20220930_g2.jpg GRAPHIC 137893
  Complete submission text file 0001126234-22-000112.txt   4535597

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20220930.xsd EX-101.SCH 26174
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20220930_cal.xml EX-101.CAL 34444
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20220930_def.xml EX-101.DEF 112195
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20220930_lab.xml EX-101.LAB 334018
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20220930_pre.xml EX-101.PRE 193966
40 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20220930_htm.xml XML 469808
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 221380637
SIC: 2834 Pharmaceutical Preparations